Protein kinase p38α signaling in dendritic cells regulates colon inflammation and tumorigenesis
- 12 December 2018
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 115 (52) , 201814705-E12322
Abstract
Dendritic cells (DCs) play pivotal roles in maintaining intestinal homeostasis, but how the DCs regulate diverse immune networks on homeostasis breakdown remains largely unknown. Here, we report that, in response to epithelial barrier disruption, colonic DCs regulate the differentiation of type 1 regulatory T (Tr1) cells through p38α-dependent IL-27 production to initiate an effective immune response. Deletion of p38α in DCs, but not in T cells, led to increased Tr1 and protected mice from dextran sodium sulfate-induced acute colitis and chronic colitis-associated colorectal cancer. We show that higher levels of IL-27 in p38α-deficient colonic cDC1s, but not cDC2s, were responsible for the increase of Tr1 cells. Moreover, p38α-dependent IL-27 enhanced IL-22 secretion from intestinal group 3 innate lymphoid cells and protected epithelial barrier function. In p38α-deficient DCs, the TAK1–MKK4/7–JNK–c-Jun axis was hyperactivated, leading to high IL-27 levels, and inhibition of the JNK–c-Jun axis suppressed IL-27 expression. ChIP assay revealed direct binding of c-Jun to the promoter of Il27p28, which was further enhanced in p38α-deficient DCs. In summary, here we identify a key role for p38α signaling in DCs in regulating intestinal inflammatory response and tumorigenesis, and our finding may provide targets for the treatment of inflammatory intestinal diseases. Significance Dendritic cells (DCs) are known to mediate immune regulatory networks in response to intestinal epithelial barrier disruption, but underlying signaling pathways and molecular mechanisms are not well understood. Here, we show that genetic disruption of p38α in DCs leads to higher levels of differentiated type 1 regulatory T cells and group 3 innate lymphoid cells. Specifically, p38α signaling in intestinal cDC1s, but not cDC2s or T cells, mediates colitis pathogenesis. Together, our results suggest that p38α MAPK represents a major signaling network in DCs that regulates inflammation and contributes to epithelial barrier function in colitis and associated colorectal cancer. Furthermore, our finding suggests that p38α signaling in DCs may represent a target for the treatment of inflammatory intestinal diseases.Keywords
Funding Information
- National Natural Science Foundation of China (91642104, 81471528 and 31670897)
- National Natural Science Foundation of China (81671399)
- 973 Basic Science Project (2014CB541803)
- Shanghai Sailing Program (17YF1416600)
This publication has 70 references indexed in Scilit:
- IL-22BP is regulated by the inflammasome and modulates tumorigenesis in the intestineNature, 2012
- Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammationNature Immunology, 2012
- Induction of regulatory Tr1 cells and inhibition of TH17 cells by IL-27Seminars in Immunology, 2011
- Mechanisms of intestinal inflammation and development of associated cancers: Lessons learned from mouse modelsMutation Research - Reviews in Mutation Research, 2010
- Regulation of JNK and p38 MAPK in the immune system: Signal integration, propagation and terminationCytokine, 2009
- Regulatory T Cells Reinforce Intestinal HomeostasisImmunity, 2009
- IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated CancerCancer Cell, 2009
- Innate and Adaptive Interleukin-22 Protects Mice from Inflammatory Bowel DiseaseImmunity, 2008
- Recognition of microorganisms and activation of the immune responseNature, 2007
- Loss of integrin αvβ8 on dendritic cells causes autoimmunity and colitis in miceNature, 2007